The COVID-19 pandemic has brought unprecedented challenges for the communities and economies worldwide, causing a profound effect on the lives of millions of people. While government and communities are trying to contain the spread, researchers are aggressively focusing their efforts towards finding a treatment and/or vaccine. We at Shimadzu are committed to supporting these efforts, through science and technology to overcome, and eventually recover from this global pandemic by working together.

Featured Applications

 

 

Application

Nucleic acid evaluation system

Application

Determination of Favipiravir in Plasma

 
 
 

Application

How Safe is Your Mask?

Application

Quality Testing for Quality Protection
- Hand Sanitisiers - 

Application

Quality Testing – Ethanol in Hand Sanitisers

Application

Quality Testing - volatile impurities hand sanitizers

 
 
 
 
 

Webinar

 

Comprehensive Analysis of Alcohols and Hand Sanitizers – Regulatory Compliance and Analytical Efficiency

Many ethanol producers have dedicated process streams to the production of hand sanitizers and their components. In this webinar,
a panel of experts will discuss the market for alcohol-based hand sanitizers, the current regulatory environment, as well as analytical
solutions to ensure the purity, potency, and safety of alcohols and hand sanitizers.] 

 
 
 
 

Simultaneous Analysis of COVID-19 Drug Candidates in Human Plasma by LC-MS/MS 

In 2019, the COVID19 caught the world almost by surprise. Its relentless spread over the world forced authorities to act rapidly to find an adequate treatment. Besides drastic measure taken to lockdown half world population, some drugs targeting single strand RNA viruses, Malaria or even bacterial strains were propelled to the FDA fast track of testing and approval to fight this new threat. Lacking deep phase I-II studies, clinical centers and hospitals had to set their own protocol to administer the treatment. Since many bioanalytical labs were equipped with LCMS/MS, corresponding stable isotope labeled standards availability became critical to monitor the drugs.

REGISTER NOW

 
 
 
 

Press Cuttings

 

Tohoku University and Shimadzu Jointly Announce a New Breath Test for Detecting COVID-19

 

Shimadzu Group Endeavors to Support Medical Professionals to Fight COVID-19 - Increasing the Production of Mobile X-Ray Systems to Accelerate Pneumonia Diagnoses

 
 
 
 

Brochure

 

Solutions for Vaccine Testing

 

 

Alsachim COVID-19 Research

Alsachim joins the fight against COVID-19

Joining the fight against the Coronavirus, Alsachim, one of the world leaders in TDM standards organic synthesis, is supporting healthcare actors to respond the urgency caused by the acceleration of clinical trials conducted to find a COVID-19 treatment....[Read more

 

Applications 

 
 

Shutdown & Startup Procedures

 
 

Liquid Chromatography

 


Good practices recommended for shutting down HPLC systems

Liquid Chromatography / Mass Spectrometry (LC-MS)


Extended storage of LC/MS and LC/MS/MS under vacuum

 
 


Manual vacuum start-up and shutdown procedures for Triple Quads


Vaccum Procedure for Q-TOF

 

High Performance Liquid Chromatography

 


Start-up High Performance Liquid Chromatograph after Extended Storage

 
 
 
 
 
 
 
 
 
 
 
 
 
 

Gas Chromatography / Mass Spectrometry (GC-MS)


Preparing your GCMS shutdown

Start-up your GCMS

 

Software Informatics

 


Shutting down LabSolutions Client/Server

TOC

 

TOC - Preparing your instrument for shutdown

 


TOC - Preparing your instrument for start-up

 
 
 
 
 
 
 
 
 
 
 
 
 
 

Gas Chromatography

 


Preparing GC shutdown


How to properly start-up your gas chromatograph

Elemental Analysis


AA - preparing your instrument for shutdown


ICPE - preparing your instrument for shutdown and start-up


ICPMS - preparing your instrument for shutdown and start-up

 
 

Social Media Updates

 

 
 

 
 

 

 
 

 

 
 

 
 

 
 

 
 

 
 

 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 

 

 
 

 

 
 
 

 
 

 
 

 
 

 
 

 
 

 
 

 

 

 

 

 
 
 
 

 

 

 

 

 

 
Top of This Page